Kollef Marin H
Department of Internal Medicine, Pulmonary and Critical Care Division, Washington University School of Medicine, St Louis, Missouri, USA.
Crit Care. 2005 Oct 5;9(5):459-64. doi: 10.1186/cc3757. Epub 2005 Jun 27.
Antimicrobial resistance has emerged as one of the most important issues complicating the management of critically ill patients with infection. This is largely due to the increasing presence of pathogenic microorganisms with resistance to existing antimicrobial agents resulting in the administration of inappropriate treatment. Effective strategies for the prevention of antimicrobial resistance within intensive care units are available and should be aggressively implemented. The importance of preventing antimicrobial resistance is magnified by the limited availability of new antimicrobial drug classes for the foreseeable future.
抗菌药物耐药性已成为使重症感染患者治疗复杂化的最重要问题之一。这主要是由于对现有抗菌药物耐药的致病微生物日益增多,导致治疗不当。重症监护病房内预防抗菌药物耐药性的有效策略是可行的,应积极实施。鉴于在可预见的未来新抗菌药物种类有限,预防抗菌药物耐药性的重要性更加凸显。